Loden v. State

222 So. 3d 312, 2017 WL 2289002, 2017 Miss. LEXIS 208
CourtMississippi Supreme Court
DecidedMay 23, 2017
DocketNo. 2016-DR-00962-SCT
StatusPublished
Cited by5 cases

This text of 222 So. 3d 312 (Loden v. State) is published on Counsel Stack Legal Research, covering Mississippi Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Loden v. State, 222 So. 3d 312, 2017 WL 2289002, 2017 Miss. LEXIS 208 (Mich. 2017).

Opinion

EN BANC ORDER

MICHAEL K. RANDOLPH,

PRESIDING JUSTICE FOR THE COURT

Before the Court, en banc, is Thomas Loden’s Successive Petition for Post-Conviction Relief, the State’s Response, and Loden’s Reply. Restated, Lo-den’s issue was whether the State’s use of midazolam as part of the three-drug, lethal-injection protocol violates Mississippi Code Section 99-19-51 (Supp. 2016) because it is not an “ultra-short acting barbiturate or other similar drug.” However, the Legislature has since amended Section 99-19-51. See 2017 Miss. Laws H.B. 638. The statute now requires an “appropriate anesthetic or sedative,” as defined by the new statute. The statute having been amended, Loden’s issue becomes moot. After due consideration, the Court finds that the successive petition should be dismissed as moot.1

IT IS THEREFORE ORDERED that the Successive Petition for Post-Conviction Relief filed by Thomas Loden is dismissed as moot.

SO ORDERED.

DICKINSON, P.J., AGREES WITH ORDER WITH SEPARATE WRITTEN STATEMENT. KITCHENS, J., OBJECTS TO THE ORDER WITH SEPARATE WRITTEN STATEMENT JOINED BY WALLER, C.J., AND KING, J.

DICKINSON, PRESIDING JUSTICE, AGREEING WITH ORDER WITH SEPARATE WRITTEN STATEMENT:

¶ 1. As a matter of fairness, this Court generally does not decide cases or dispose of motions for reasons the losing parties have had no opportunity to brief. Today we do so because Loden’s claim was based on a portion of Section 99-19-51 that was amended while his motion was pending before this Court. He now is subject to a new version of Section 99-19-51. The basis for today’s order is the mootness of his current claim, and in no way addresses whether midazolam is or is not a permissible drug under the statute now in effect.

KITCHENS, JUSTICE, OBJECTING TO THE ORDER WITH SEPARATE WRITTEN STATEMENT:

¶ 2. In view of the statutory change, I would order supplemental briefing to allow the parties the opportunity to present arguments under the new statute.

WALLER, C.J., AND KING, J., JOIN THIS SEPARATE WRITTEN STATEMENT.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
222 So. 3d 312, 2017 WL 2289002, 2017 Miss. LEXIS 208, Counsel Stack Legal Research, https://law.counselstack.com/opinion/loden-v-state-miss-2017.